Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Celebrex
Active Ingredient: Celecoxib 100mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Celebrex
Active Ingredient: Celecoxib 200mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Celebrex
Active Ingredient: Celecoxib 400mg
Dosage Form: Capsule
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Caguas, Puerto Rico
Product: Daonil
Active Ingredient: Glibenclamide 5mg
Dosage Form: Tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturers: Aventis Pharma Limited, Verna Industrial Estate, Verna, Goa, India
Sanofi Winthrop Industrie, Compiegne, France
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Dated this 15th day of May 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).